Jump to content
RemedySpot.com

Worldwide, Cancer has Biggest Economic Impact of Any Cause of Death

Rate this topic


Guest guest

Recommended Posts

" Cancer care costs are a financial burden to patients, their families, and

society as a whole. In 2006 medical expenses from cancer care in the United

States were an estimated $104.1 billion. As the population ages, costs are

expected to continue to increase as cancer prevalence rises. In addition, the

development of expensive, targeted treatment strategies that are becoming the

standard of care will most likely increase cancer costs. According to the World

Health Organization (WHO) between 2004 and 2030, global cancer deaths will

increase from 7.4 million to 11.8 million and cancer will be the leading cause

of death this year followed by heart disease and stroke. " Remainder of story:

http://www.caring4cancer.com/go/cancer/news?NewsItemId=45091

____________________________

More on medical marijuana and its ingredients. This is the ingredient I think

Tracey was describing. The active ingredient in marijuana is

delta-9-tetrahydrocannabinol (THC).

http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/D/Drugs.html#marijuana

___________________________

(cancer) " … a cannabinoid-based therapeutic strategy for neural diseases devoid

of undesired psychotropic side effects could find in CBD [cannabidiol] a

valuable compound in cancer therapies along with the perspective of evaluating a

synergistic effect with other cannabinoid molecules and/or with other

chemotherapeutic agents as well as with radiotherapy. " Journal of Pharmacology

and Experimental Therapeutics, 2004.

http://jpet.aspetjournals.org/content/308/3/838.full.pdf

http://proxychi.baremetal.com/www.drugsense.org/cms/files/Cannabis%20Clinical%20\

Research.pdf

__________________________

Marijuana and its derivatives have been used in medicine

for many centuries, and currently there is a renewed interest

in the study of the therapeutic effects of cannabinoids. Cannabinoids

produce their effects by binding to specific plasma

membrane G protein-coupled receptors. To date, two cannabinoid

receptors have been characterized: the CB1 receptor,

expressed primarily in the brain and in some peripheral

tissues, and CB2 receptors, expressed by cells of the immune

system.

http://jpet.aspetjournals.org/content/308/3/838.full.pdf

_____________________

FYI,

Lottie Duthu

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...